Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 3—March 2008

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

Andriyan Grinev*, Sylvester Daniel*, Susan L. Stramer†, Susan N. Rossmann‡, Sally Caglioti§, and Maria Rios*Comments to Author 
Author affiliations: *Food and Drug Administration, Bethesda, Maryland, USA; †American Red Cross, Gaithersburg, Maryland, USA; ‡Gulf Coast Regional Blood Center, Houston, Texas, USA; §Blood System Laboratories, Tempe, Arizona, USA;

Main Article

Table 3

Deduced amino acid substitutions in 8 completely sequenced West Nile virus isolates compared with isolate WN-NY99*

Isolate NS4B

2488 2549 2755 2788 2820 2826 2842 3056 3104 3132 3191 3238 3240
WN-NY99 Ser Lys Gly Asn Ser Glu Lys Pro Arg Arg Met Gln Pro Total
FDA/HU-02 5
ARC10–02 Gly 3
BSL5–03 Arg 6
BSL5–04 Ser Arg Lys Gln 8
GCTX1–05 Arg Ser Leu Arg Cys Ser Thr 16
GCTX2–05 Ser 3
BSL2–05 Gly Arg Gln 10
BSL13–05 Gly Arg Gln 8

*NS, nonstructural.

Main Article

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.